The Transplanted Decidua–Placenta Axis in Human Uterus Transplantation: Integrating Ischemia–Reperfusion Injury, Alloimmune Surveillance, and Cervicovascular Remodeling to Explain Preeclampsia, Prematurity, and Live Birth
Abstract
Objective: Pregnancy following uterus transplantation (UTx) has moved beyond proof-of-concept, yet consistently exhibits a high-risk obstetric profile that remains insufficiently explained. This review aimed to examine whether these outcomes can be understood through a unified mechanistic framework, conceptualized here as the transplanted decidua–placenta axis, linking graft biology with placental development and clinical phenotype.
Methods: A structured literature review was conducted across PubMed/MEDLINE, Embase, Scopus, Web of Science, and Cochrane Library from inception to the most recent update. Studies were selected based on predefined inclusion criteria focusing on human UTx outcomes, graft pathology, placental biology, and immunological mechanisms. Screening and eligibility assessment were performed independently, with discrepancies resolved by consensus. Data were synthesized qualitatively, integrating clinical, experimental, and mechanistic evidence rather than pursuing meta-analysis, given heterogeneity across study designs.
Results: From 1,322 records identified, 25 studies were included following systematic screening. Across these, a recurring pattern emerged—UTx pregnancies appear shaped by pre-pregnancy graft injury, including ischemia–reperfusion damage and subclinical rejection, followed by a superimposed dual alloimmune interface during gestation. This sequence seems to influence decidualization, disrupt spiral artery remodeling, and constrain trophoblast invasion. Clinically, these mechanisms converge on a phenotype characterized by hypertensive disorders, fetal growth restriction, abnormal placentation, and prematurity. Notably, evidence remains fragmented, often indirect, yet increasingly convergent.
Conclusion: UTx pregnancy may represent a distinct model of placental dysfunction rather than a conventional gestation under immunosuppression. Recognizing this shift has implications for surveillance, biomarker development, and future research—although, at present, much still rests on inference rather than direct proof.
Sumbu Desidua–Plasenta pada Transplantasi Uterus Manusia: Integrasi Cedera Iskemia–Reperfusi, Surveilans Aloimun, serta Remodeling Servikovaskular sebagai Mekanisme yang Menjelaskan Preeklamsia, Prematuritas, dan Keberhasilan Kelahiran Hidup
Abstrak
Tujuan: Kehamilan setelah transplantasi uterus (UTx) telah melampaui tahap pembuktian konsep, namun secara konsisten menunjukkan profil obstetri berisiko tinggi yang hingga kini belum sepenuhnya dapat dijelaskan. Tinjauan ini bertujuan untuk mengkaji apakah luaran tersebut dapat dipahami melalui suatu kerangka mekanistik terpadu, yang dalam tinjauan ini dikonseptualisasikan sebagai transplanted decidua–placenta axis, yang menghubungkan biologi graft dengan perkembangan plasenta dan fenotipe klinis.
Metode: Tinjauan literatur terstruktur dilakukan melalui basis data PubMed/MEDLINE, Embase, Scopus, Web of Science, dan Cochrane Library sejak awal publikasi hingga pembaruan terkini. Studi dipilih berdasarkan kriteria inklusi yang telah ditetapkan sebelumnya, dengan fokus pada luaran klinis UTx pada manusia, patologi graft, biologi plasenta, serta mekanisme imunologis. Proses penyaringan dan penilaian kelayakan dilakukan secara independen, dengan penyelesaian perbedaan melalui konsensus. Sintesis data dilakukan secara kualitatif dengan mengintegrasikan bukti klinis, eksperimental, dan mekanistik, tanpa meta-analisis mengingat heterogenitas desain studi.
Hasil: Dari 1.322 rekaman yang teridentifikasi, sebanyak 25 studi dimasukkan setelah proses seleksi sistematis. Secara konsisten, ditemukan pola bahwa kehamilan UTx tampaknya dipengaruhi oleh cedera graft pra-kehamilan, termasuk kerusakan akibat iskemia–reperfusi dan rejeksi subklinis, yang kemudian diikuti oleh adanya paparan alloimun ganda selama gestasi. Rangkaian proses ini diduga memengaruhi desidualisasi, mengganggu remodeling arteri spiralis, serta membatasi invasi trofoblas. Secara klinis, mekanisme tersebut berkonvergensi menjadi suatu fenotipe yang ditandai oleh gangguan hipertensi kehamilan, restriksi pertumbuhan janin, abnormalitas implantasi plasenta, serta prematuritas. Bukti yang tersedia masih terfragmentasi dan sebagian bersifat tidak langsung, namun menunjukkan kecenderungan konvergen.
Kesimpulan: Kehamilan pada UTx kemungkinan merepresentasikan suatu model disfungsi plasenta yang berbeda, bukan sekadar kehamilan konvensional dalam kondisi imunosupresi. Pergeseran paradigma ini memiliki implikasi terhadap strategi surveilans, pengembangan biomarker, serta arah penelitian ke depan—meskipun hingga saat ini sebagian besar kesimpulan masih bersifat inferensial dan belum sepenuhnya terkonfirmasi secara langsung.
Keywords
Full Text:
PDFReferences
Castellón LAR, Amador MIG, González RED, Eduardo MSJ, Díaz-García C, Kvarnström N, et al. The history behind successful uterine transplantation in humans. JBRA Assist Reprod. 2017;21:126-134. https://doi.org/10.5935/1518-0557.20170028
Johannesson L, Järvholm S. Uterus transplantation: current progress and future prospects. Int J Womens Health. 2016;8:43-51. https://doi.org/10.2147/IJWH.S75635
Ejzenberg D, Mendes LR, Haddad LB, Baracat EC, D'Albuquerque LA, Andraus W. Uterine transplantation: a systematic review. Clinics (Sao Paulo). 2016;71:679-683. https://doi.org/10.6061/clinics/2016(11)10
Richards EG, Farrell RM, Ricci S, Perni U, Quintini C, Tzakis A, et al. Uterus transplantation: state of the art in 2021. J Assist Reprod Genet. 2021;38:2251-2259. https://doi.org/10.1007/s10815-021-02245-7
Johannesson L, Richards E, Reddy V, Walter J, Olthoff K, Quintini C, et al. The first 5 years of uterus transplant in the US: a report from the United States Uterus Transplant Consortium. JAMA Surg. 2022;157:790-797. https://doi.org/10.1001/jamasurg.2022.2612
Brännström M, Racowsky C, Carbonnel M, Wu J, Gargiulo A, Adashi EY, et al. Uterus transplantation: from research, through human trials and into the future. Hum Reprod Update. 2023;29:521-544. https://doi.org/10.1093/humupd/dmad012
Veroux M, Scollo P, Giambra MM, Roscitano G, Giaquinta A, Setacci F, et al. Living-donor uterus transplantation: a clinical review. J Clin Med. 2024;13:775. https://doi.org/10.3390/jcm13030775
Testa G, McKenna GJ, Wall A, Bayer J, Gregg AR, Warren AM, et al. Uterus transplant in women with absolute uterine-factor infertility. JAMA. 2024;332:817-824. https://doi.org/10.1001/jama.2024.11679
Brännström M, Bokström H, Hagberg H, Carlsson Y. Maternal and perinatal outcomes of live births after uterus transplantation: a systematic review. Acta Obstet Gynecol Scand. 2025;104:559-578. https://doi.org/10.1111/aogs.15003
Pérez-Blanco A, Seoane JA, Pallás TA, Nieto-Moro M, Calonge RN, de la Fuente A, et al. Uterus transplantation as a surgical innovation. J Bioeth Inq. 2023;20:367-378. https://doi.org/10.1007/s11673-023-10272-5
Kisu I, Matsuda R, Shiraishi T, Hayashi R, Matoba Y, Tamate M, et al. Graft failure after uterus transplantation in 16 recipients: a review. J Clin Med. 2023;12:2032. https://doi.org/10.3390/jcm12052032
Karlsson CC, Dahm-Kähler P, Kvarnström N, Mölne J, Broecker V, Brännström M. Hysterectomy after uterus transplantation and detailed analyses of graft failures. Acta Obstet Gynecol Scand. 2022;101:355-363. https://doi.org/10.1111/aogs.14304
Broecker V, Brännström M, Bösmüller H, Sticová E, Malušková J, Chiesa-Vottero A, et al. Reproducibility of rejection grading in uterus transplantation: a multicenter study. Transplant Direct. 2023;9:e1535. https://doi.org/10.1097/TXD.0000000000001535
Walter JR, O'Neill KE. Reproductive technology considerations in uterus transplant. Clin Obstet Gynecol. 2022;65:68-75. https://doi.org/10.1097/GRF.0000000000000684
Johannesson L, Anderson S, Putman JM, Gunby RT, Zhang L, Testa G, et al. Persistence pays off: live birth after uterus transplant, overcoming recurrent pregnancy loss with cerclage placement. J Clin Med. 2023;12:6463. https://doi.org/10.3390/jcm12206463
Zitkute V, Kvietkauskas M, Maskoliunaite V, Leber B, Ramasauskaite D, Strupas K, et al. Melatonin and glycine reduce uterus ischemia/reperfusion injury in a rat model of warm ischemia. Int J Mol Sci. 2021;22:8373. https://doi.org/10.3390/ijms22168373
Sousa CH, Mercier M, Rioux-Leclercq N, Flecher E, Bendavid C, Val-Laillet D, et al. Hypothermic machine perfusion in uterus transplantation in a porcine model: a proof of concept and the first results in graft preservation. Acta Obstet Gynecol Scand. 2025;104:461-473. https://doi.org/10.1111/aogs.15056
Iske J, Elkhal A, Tullius SG. The fetal-maternal immune interface in uterus transplantation. Trends Immunol. 2020;41:213-224. https://doi.org/10.1016/j.it.2020.01.006
Sun JY, Wu R, Xu J, Xue HY, Lu XJ, Ji J. Placental immune tolerance and organ transplantation: underlying interconnections and clinical implications. Front Immunol. 2021;12:705950. https://doi.org/10.3389/fimmu.2021.705950
Parham P, Norman PJ, Abi-Rached L, Hilton HG, Guethlein LA. Immunogenetics of human placentation. Placenta. 2012;33:S71-80. https://doi.org/10.1016/j.placenta.2011.11.020
Carter AM. Unique aspects of human placentation. Int J Mol Sci. 2021;22:8099. https://doi.org/10.3390/ijms22158099
Sojka DK, Yang L, Yokoyama WM. Uterine natural killer cells: to protect and to nurture. Birth Defects Res. 2018;110:1531-1538. https://doi.org/10.1002/bdr2.1419
Yang X, Yang Y, Yuan Y, Liu L, Meng T. The roles of uterine natural killer cells and KIR/HLA-C combination in the development of preeclampsia: a systematic review. Biomed Res Int. 2020;2020:4808072. https://doi.org/10.1155/2020/4808072
Deer E, Herrock O, Campbell N, Cornelius D, Fitzgerald S, Amaral LM, et al. The role of immune cells and mediators in preeclampsia. Nat Rev Nephrol. 2023;19:257-270. https://doi.org/10.1038/s41581-022-00670-0
Hiby SE, Walker JJ, O'Shaughnessy KM, Redman CW, Carrington M, Trowsdale J, et al. Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med. 2004;200:957-965. https://doi.org/10.1084/jem.20041214
DOI: http://dx.doi.org/10.24198/obgynia.v9i3.1134
Refbacks
- There are currently no refbacks.

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
_CROSREF22.jpg)










